以幹細胞為基礎的軟骨再生市場：按幹細胞類型、治療方法、最終用戶、地區和區域分類。

Stem Cell Cartilage Regeneration Market, by Stem Cell Type, by Treatment, By End User and by Region, and By Geography

出版日期: 2026年04月28日 | 出版商:

Coherent Market Insights | 英文 250+ Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

預計到2026年，基於幹細胞的軟骨再生市場規模將達到5.271億美元，2033年將達到9.886億美元。預計從2026年到2033年，該市場將以9.4%的複合年成長率成長。

報告範圍		報告詳情
基準年：	2025	2026年市場規模：	5.271億美元
歷史數據時期：	2020年至2024年	預測期：	2026年至2033年
2026年至2033年預測期間的複合年成長率：	9.40%	2033年市場規模預測：	9.886億美元

在軟骨再生中，幹細胞具有多功能分化和自我更新能力，使其成為理想的種子細胞。再生醫學產業的蓬勃發展以及間質幹細胞是軟骨再生領域中應用最廣泛的幹細胞。此外，成體幹細胞具有分化為軟骨、骨骼、脂肪或軟組織的潛能。以幹細胞為基礎的療法是軟骨再生功能性替代的關鍵所在。成體幹細胞可以透過微創方式從脂肪組織或骨髓中取得。脂肪來源的幹細胞具有很高的分化為軟骨的潛能，且數量遠高於骨髓來源的幹細胞。

市場動態

預計研發活動的活性化將推動預測期內市場成長。例如，根據2020年8月發表在《史丹佛醫學》雜誌上的數據，史丹佛大學醫學院的研究人員發現了一種在小鼠和人體組織中再生關節軟骨墊的方法。史丹佛大學的研究人員闡明了一種再生關節軟骨的方法：首先對關節組織造成輕微損傷，然後利用化學訊號誘導骨骼幹細胞在癒合過程中生長。

本研究的主要特點：

本研究確定了各個細分市場的潛在商機，並為該市場說明了一個有吸引力的投資提案矩陣。
此外，本研究還深入分析了市場促進因素、限制因素、機會、新產品發布和批准、市場趨勢、區域展望以及領先企業採取的競爭策略。
本研究根據以下參數分析了全球幹細胞軟骨再生市場的主要參與者：公司概況、產品系列、主要亮點、財務表現和策略。
這份「全球幹細胞軟骨再生市場」報告旨在為產業內的各類相關人員提供參考，包括投資者、供應商、產品製造商、經銷商、新參與企業和金融分析師。
相關人員可以透過利用各種策略矩陣來分析全球幹細胞軟骨再生市場，從而簡化決策過程。

北美洲
- 美國
- 加拿大
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 其他拉丁美洲國家
歐洲
- 英國
- 德國
- 義大利
- 法國
- 西班牙
- 俄羅斯
- 其他歐洲國家
亞太地區
- 中國
- 印度
- 日本
- ASEAN
- 澳洲
- 韓國
- 其他亞太國家
中東
- GCC
- 以色列
- 其他中東國家
非洲
- 北非
- 中非
- 南非

第9章競爭情勢

Theracell Advanced Biotechnology Ltd
Orthocell Ltd.
Xintela AB
CellGenix GmbH
Merck KGaA
Osiris Therapeutics, Inc
BioTissue SA
Vericel Corporation

第10章

調查方法
關於本公司

簡介目錄

Product Code: CMI2448

Stem Cell Cartilage Regeneration Market is estimated to be valued at USD 527.1 Mn in 2026 and is expected to reach USD 988.6 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.4% from 2026 to 2033.

Report Coverage		Report Details
Base Year:	2025	Market Size in 2026:	USD 527.1 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2026 To 2033
Forecast Period 2026 to 2033 CAGR:	9.40%	2033 Value Projection:	USD 988.6 Mn

In cartilage regeneration, stem cells have the potential for multiple differentiation and self-replication, making them an ideal choice for use as seed cells. The growing regenerative medicine industry and increasing demand for stem cells in the development of various types of cell therapies are expected to drive the growth of the market over the forecast period. Mesenchymal stem cells are the most widely applied stem cells in the field of cartilage regeneration. Furthermore, adult stem cells have the potential to differentiate into cartilage, bone, fat or soft tissue. Stem cell-based therapy has become a key focus in the functional replacement of cartilage regeneration. Adult stem cells can be extracted by minimally invasive methods from fat tissue and bone marrow. Fat-derived stem cells exhibit an enhanced ability to differentiate into cartilage and are found in higher numbers than bone marrow.

Market Dynamics

Increasing research and development activities is expected to drive the market over the forecast period for instance, in August 2020, data was published in the Stanford Medicine journal, according to that, researchers at the Stanford University School of Medicine have discovered a way to regenerate, in mice and human tissue, the cushion of cartilage found in joints. The Stanford researchers figured out how to regrow articular cartilage by first causing slight injury to the joint tissue, then using chemical signals to steer the growth of skeletal stem cells as the injuries heal.

Key features of the study:

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global stem cell cartilage regeneration market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study are Theracell Advanced Biotechnology Ltd., Orthocell Ltd., Xintela AB, CellGenix GmbH, Merck KGaA, Osiris Therapeutics, Inc., BioTissue SA, and Vericel Corporation. Insights from this report will allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global stem cell cartilage regeneration market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global stem cell cartilage regeneration market

Detailed Segmentation:

Global Stem Cell Cartilage Regeneration Market, By Stem Cell Type (Revenue, USD Mn, 2021 - 2033)
Hematopoietic Stem Cells (HSCs)
Pluripotent Stem Cells (iPSC/ESCs)
Mesenchymal Stem Cells (MSCs)
Global Stem Cell Cartilage Regeneration Market, By Treatment (Revenue, USD Mn, 2021 - 2033)
Microfracture
Osteochondral Transplant
Autologous Chondrocyte Implantation
Stem Cell Injections
Global Stem Cell Cartilage Regeneration Market, By End User (Revenue, USD Mn, 2021 - 2033)
Hospitals
Ambulatory Surgical Centers
Global Stem Cell Cartilage Regeneration Market, By Region (Revenue, USD Mn, 2021 - 2033)
North America
- By Country:
  - U.S.
  - Canada
Latin America
- By Country:
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- By Country:
  - Germany
  - U.K.
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- By Country
  - China
  - India
  - Japan
  - Australia
  - South Korea
  - ASEAN
  - Rest of Asia Pacific
Middle East
- By Country:
  - GCC
  - Israel
  - Rest of Middle East
Africa
- By Country/Region:
  - South Africa
  - Central Africa
  - North Africa
Company Profiles
Theracell Advanced Biotechnology Ltd *
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
Orthocell Ltd.
Xintela AB
CellGenix GmbH
Merck KGaA
Osiris Therapeutics, Inc.
BioTissue SA
Vericel Corporation

"*" marked represents similar segmentation in other categories in the respective section.

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snapshot, By Stem Cell Type
- Market Snapshot, By Treatment
- Market Snapshot, By End User
- Market Snapshot, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Key Highlights
- Product Launch
- Technological Advancements
- PEST Analysis
- Regulatory Scenario
- Mergers and Acquisitions

4. Global Stem Cell Cartilage Regeneration Market

Economic Impact
Impact on Supply and Demand

5. Global Stem Cell Cartilage Regeneration Market, By Stem Cell Type, 2021 €" 2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Hematopoietic Stem Cells (HSCs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
Pluripotent Stem Cells (iPSC/ESCs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
Mesenchymal Stem Cells (MSCs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)

6. Global Stem Cell Cartilage Regeneration Market, By Treatment, 2021 €" 2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Microfracture
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
Osteochondral Transplant
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
Autologous Chondrocyte Implantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021€"2033, (US$ Million)
Stem Cell Injections
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2021 - 2033, (US$ Million)

7. Global Stem Cell Cartilage Regeneration Market, By End User, 2021 €" 2033, (US$ Million)

Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-O-Y Growth Analysis, 2022 €" 2033
- Segment Trends
Hospitals & Clinics
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2021-2033, ((US$) Million)
Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-O-Y Growth, 2021-2033, ((US$) Million)

8. Global Stem Cell Cartilage Regeneration Market, By Region, 2021 €" 2033, (US$ Million)

Introduction
- Market Share Analysis, By Region, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, For Regions, 2022€"2033
- Regional Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Stem Cell Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Million)
  - U.S.
  - Canada
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Stem Cell Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Million)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Stem Cell Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Million)
  - U.K.
  - Germany
  - Italy
  - France
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Stem Cell Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Million)
  - China
  - India
  - Japan
  - ASEAN
  - Australia
  - South Korea
  - Rest of Asia Pacific
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Stem Cell Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 €" 2033, (US$ Million)
  - GCC
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Stem Cell Type, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 €" 2033, (US$ Million)
  - North Africa
  - Central Africa
  - South Africa

9. Competitive Landscape

Theracell Advanced Biotechnology Ltd
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Orthocell Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Xintela AB
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
CellGenix GmbH
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Merck KGaA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Osiris Therapeutics, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
BioTissue SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
Vericel Corporation
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies